RECRUITING

Emergency Medicine Pharmacist Prescriptive Authority for Resolution of Outpatient Prescription Issues

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The study aims to document the utility of Methodist Charlton Medical Center (MCMC's)Emergency Medicine Pharmacist (EMP) Collaborative Practice Agreement (CPA )utilization for the resolution of outpatient prescription issues. Evaluation of utility will involve describing all EMP-written prescriptions pursuant to resolution of prescription issues realized after discharge.

Official Title

Emergency Medicine Pharmacist Prescriptive Authority for Resolution of Outpatient Prescription Issues: a Descriptive Study

Quick Facts

Study Start:2023-12-15
Study Completion:2026-12-15
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06222424

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:Not specified
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD, ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Patients at MCMC who had a prescription sent by an EMP between November 1, 2021 and June 30, 2023 and a progress note and documenting the reason for the call and action taken by the EMP.
  1. * CPA actions were misclassified as discharge prescription issue resolutions.
  2. * Patients with prescriptions pursuant to late culture review, formulation changes not requiring a new prescription, prescription transfers to another pharmacy, or simple retransmission of prescriptions.
  3. * Patients documented to have left the ED against medical advice.

Contacts and Locations

Study Contact

Jeff Wilson
CONTACT
214-947-1279
mhsirb@mhd.com
Colette N Ndjom
CONTACT
214-947-1289
mhsirb@mhd.com

Principal Investigator

Kevin Burnham, Pharm.D.
PRINCIPAL_INVESTIGATOR
Methodist Health System

Study Locations (Sites)

Clinical Research Institute at Methodist Health System
Dallas, Texas, 75203
United States

Collaborators and Investigators

Sponsor: Methodist Health System

  • Kevin Burnham, Pharm.D., PRINCIPAL_INVESTIGATOR, Methodist Health System

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-12-15
Study Completion Date2026-12-15

Study Record Updates

Study Start Date2023-12-15
Study Completion Date2026-12-15

Terms related to this study

Additional Relevant MeSH Terms

  • Outpatient Prescription Issues